Repair of bone defects using synthetic mimetics of collagenous extracellular matrices

We have engineered synthetic poly(ethylene glycol) (PEG)–based hydrogels as cell-ingrowth matrices for in situ bone regeneration. These networks contain a combination of pendant oligopeptide ligands for cell adhesion (RGDSP) and substrates for matrix metalloproteinase (MMP) as linkers between PEG chains. Primary human fibroblasts were shown to migrate within these matrices by integrin- and MMP-dependent mechanisms. Gels used to deliver recombinant human bone morphogenetic protein-2 (rhBMP-2) to the site of critical- sized defects in rat crania were completely infiltrated by cells and were remodeled into bony tissue within five weeks. Bone regeneration was dependent on the proteolytic sensitivity of the matrices and their architecture. The cell-mediated proteolytic invasiveness of the gels and entrapment of rhBMP-2 resulted in efficient and highly localized bone regeneration.

[1]  J. Wozney,et al.  Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. , 1998, Journal of biomedical materials research.

[2]  Thiennu H. Vu,et al.  Matrix metalloproteinases: effectors of development and normal physiology. , 2000, Genes & development.

[3]  J. Wozney,et al.  Delivering on the promise of bone morphogenetic proteins. , 2001, Trends in biotechnology.

[4]  J. A. Hubbell,et al.  Separation of the arterial wall from blood contact using hydrogel barriers reduces intimal thickening after balloon injury in the rat: the roles of medial and luminal factors in arterial healing. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. McPherson,et al.  Polymeric precipitants for the crystallization of macromolecules. , 1995, Biochemical and biophysical research communications.

[6]  J. Hubbell,et al.  Bioactive biomaterials. , 1999, Current opinion in biotechnology.

[7]  P. Speight,et al.  Effect of poly DL-lactide--co-glycolide implants and xenogeneic bone matrix-derived growth factors on calvarial bone repair in the rabbit. , 1994, Biomaterials.

[8]  P Rüegsegger,et al.  Micro-tomographic imaging for the nondestructive evaluation of trabecular bone architecture. , 1997, Studies in health technology and informatics.

[9]  J. Hubbell,et al.  Protein delivery from materials formed by self-selective conjugate addition reactions. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[10]  P Rüegsegger,et al.  Non-invasive bone biopsy: a new method to analyse and display the three-dimensional structure of trabecular bone. , 1994, Physics in medicine and biology.

[11]  J H Brekke,et al.  Principles of tissue engineering applied to programmable osteogenesis. , 1998, Journal of biomedical materials research.

[12]  L. Griffith,et al.  Tissue Engineering--Current Challenges and Expanding Opportunities , 2002, Science.

[13]  Kazutoshi Nozaki,et al.  A biodegradable polymer as a cytokine delivery system for inducing bone formation , 2001, Nature Biotechnology.

[14]  M. Zimmerman,et al.  Evaluation of poly(DTH carbonate), a tyrosine-derived degradable polymer, for orthopedic applications. , 1995, Journal of biomedical materials research.

[15]  J. Wozney,et al.  Bone Formation with Use of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2)* , 1997, The Journal of bone and joint surgery. American volume.

[16]  J. Hollinger,et al.  Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2). , 1994, Journal of biomedical materials research.

[17]  S. Schwendeman,et al.  Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) , 2000, Nature Biotechnology.

[18]  V. Rosen,et al.  Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. , 1998, Clinical orthopaedics and related research.

[19]  G. Zych,et al.  Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the Treatment of Tibial Nonunions: A Prospective, Randomized Clinical Trial Comparing rhOP-1 with Fresh Bone Autograft* , 2001, The Journal of bone and joint surgery. American volume.

[20]  D. Kingsley,et al.  What do BMPs do in mammals? Clues from the mouse short-ear mutation. , 1994, Trends in genetics : TIG.

[21]  H F Sailer,et al.  Slow and continuous application of human recombinant bone morphogenetic protein via biodegradable poly(lactide-co-glycolide) foamspheres. , 2002, International journal of oral and maxillofacial surgery.

[22]  J. Hubbell,et al.  Systematic modulation of Michael-type reactivity of thiols through the use of charged amino acids. , 2001, Bioconjugate chemistry.

[23]  J. Woessner,et al.  Matrix metalloproteinases and TIMPs , 2000 .

[24]  O. Böstman,et al.  Foreign-body reactions to fracture fixation implants of biodegradable synthetic polymers. , 1990, The Journal of bone and joint surgery. British volume.

[25]  F. Weber,et al.  Disulfide bridge conformers of mature BMP are inhibitors for heterotopic ossification. , 2001, Biochemical and biophysical research communications.

[26]  W. Sebald,et al.  Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. , 1996, European journal of biochemistry.

[27]  Robert Langer,et al.  Photopolymerizable degradable polyanhydrides with osteocompatibility , 1999, Nature Biotechnology.

[28]  H. Gundersen,et al.  Quantification of connectivity in cancellous bone, with special emphasis on 3-D reconstructions. , 1993, Bone.

[29]  P. Boyne.  Animal studies of application of rhBMP-2 in maxillofacial reconstruction. , 1996, Bone.

[30]  J. Wozney,et al.  rhBMP‐Collagen Sponges as Osteoinductive Devices: Effects of in Vitro Sponge Characteristics and Protein pI on in Vivo rhBMP Pharmacokinetics , 1999, Annals of the New York Academy of Sciences.

[31]  D. Chamberland,et al.  Radiomorphometry and biomechanical assessment of recombinant human bone morphogenetic protein 2 and polymer in rabbit radius ostectomy model. , 1998, Journal of biomedical materials research.

[32]  J. Wozney,et al.  Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: A correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model. , 2000, Journal of biomedical materials research.

[33]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988, Science.

[34]  J. McPherson,et al.  The human immune response to reconstituted bovine collagen. , 1986, Journal of immunology.

[35]  Alyssa Panitch,et al.  Biologically engineered protein-graft-poly(ethylene glycol) hydrogels: a cell adhesive and plasmin-degradable biosynthetic material for tissue repair. , 2002, Biomacromolecules.

[36]  J. West,et al.  Cell migration through defined, synthetic extracellular matrix analogues , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  J. Dasch,et al.  Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives. , 1990, Clinical orthopaedics and related research.

[38]  Z. Werb,et al.  How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.

[39]  J. Schmitt,et al.  Bone morphogenetic proteins: An update on basic biology and clinical relevance , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[40]  Richard A.F. Clark,et al.  The Molecular and Cellular Biology of Wound Repair , 2012, Springer US.